Investigational drug · Phase 2
SRP-001
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acute Pain, Postoperative Pain, Pain.
Phase 2Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "SRP-001"
First trial start
2026
Nov 30, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "SRP-001", any sponsor or status.
Conditions studied
As listed on its trial records.
- Acute Pain
- Postoperative Pain
- Pain
- Dental Pain
Approved drugs for the same conditions: Acute pain · Pain and anesthesia
Largest trials
Live from ClinicalTrials.gov: studies naming "SRP-001" as an intervention, largest first.
- A Study Evaluating the Efficacy and Safety of Novel Non-Opioid SRP-001 in Acute Pain After Molar ExtractionPivotal-lookingNot yet recruiting
South Rampart Pharma, Inc.Industry
NCT07945431 · 130 participants (planned) · Start Nov 30, 2026 · Primary completion Feb 28, 2027
Drug: SRP-001; Matching Placebo for SRP-001 · For: Acute Pain; Postoperative Pain; Pain and 1 more
Sites: Salt Lake City, Utah
Newest research
PubMed records naming it or its code names, newest first.
- A non-toxic analgesic elicits cell-specific genomic and epigenomic modulation by targeting the PAG brain region.
Bazan HA, Giles BL, Bhattacharjee S, et al. · Neurobiol Pain 2025
- Transcriptomic signature, bioactivity and safety of a non-hepatotoxic analgesic generating AM404 in the midbrain PAG region.
Bazan HA, Bhattacharjee S, Reid MM, et al. · Sci Rep 2024
- Transcriptomic signature, bioactivity and safety of a non-hepatoxic analgesic generating AM404 in the mid-brain PAG region.
Bazan H, Bhattacharjee S, Reid M, et al. · Res Sq 2023
Also in development for Acute Pain
- CebranopadolTRN-228Phase 34 trials
Adneuris Therapeutics, Inc. · Pain, Acute Pain, Chronic Pain
- MR-107A-02Phase 31 trial
Viatris Specialty LLC · Acute Pain, Post Operative Pain, Pain
- matched to VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- GRT7040Phase 21 trial
Grünenthal GmbH · Acute Pain, Bunionectomy
- LY4515100Phase 21 trial
Eli Lilly · Acute Pain, Molar, Molar, Third
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.